Synthetic Metabolic and Genetic Networks for Medical Diagnosics
NCT04518072 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 134
Last updated 2025-06-11
Summary
This is a category 3 human study, prospective, comparative, in parallel groups. A comparative qualitative and quantitative analysis of several markers in 250 samples is proposed.
Conditions
Interventions
- OTHER
-
Blood sample (1 EDTA tube, 1 SST tube, 1 Streck tube) and urine sample (100 ml)
assessed biomarker in clinical samples
Sponsors & Collaborators
-
MICALIS
collaborator UNKNOWN -
CBS
collaborator UNKNOWN -
University Hospital, Montpellier
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-06
- Primary Completion
- 2025-04-19
- Completion
- 2025-06-06
Countries
- France
Study Locations
More Related Trials
-
Analysis of Circulating Tumor Markers in Blood - ALCINA 5
NCT07060950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers
NCT06861621 ·Status: RECRUITING
-
Combating the Diagnostic Impasse in Mitochondrial Diseases: a Transcriptomic Approach in Fibroblasts and Blood Cells
NCT06621732 ·Status: RECRUITING ·Phase: NA
-
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
NCT06851975 ·Status: RECRUITING ·Phase: NA
-
Circulating Tumor DNA Exposure in Peripheral Blood
NCT03517332 ·Status: UNKNOWN
-
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
NCT00918008 ·Status: TERMINATED
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
NCT00898781 ·Status: TERMINATED
-
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
NCT01457196 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer
NCT00491621 ·Status: TERMINATED ·Phase: NA
-
Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.
NCT05083494 ·Status: UNKNOWN
-
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
NCT05630131 ·Status: COMPLETED
-
Genetic Testing for Men With Metastatic Prostate Cancer
NCT03503097 ·Status: TERMINATED
-
Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis
NCT01268956 ·Status: UNKNOWN
-
Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors
NCT06939049 ·Status: COMPLETED
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
NCT03727009 ·Status: TERMINATED
-
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
NCT06896162 ·Status: RECRUITING ·Phase: NA
-
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
NCT03265496 ·Status: TERMINATED ·Phase: NA
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer
NCT05356585 ·Status: WITHDRAWN
-
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
NCT04104633 ·Status: COMPLETED ·Phase: NA
-
Metadherin mRNA Expression in Bladder Cancer
NCT04286672 ·Status: UNKNOWN
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Cell-free DNA in Hereditary And High-Risk Malignancies 1
NCT04261972 ·Status: ACTIVE_NOT_RECRUITING